Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

1 in non-Hodgkin's lymphoma. Under a strategic alliance established in 2001, Cytokinetics and GlaxoSmithKline (GSK) are conducting research and development activities focused on the potential treatment of cancer. GSK has obtained an option for the joint development and commercialization of ispinesib and SB-743921, exercisable during a defined period. Cytokinetics and GSK are conducting collaborative research activities directed to the mitotic kinesin centromere-associated protein E (CENP-E). GSK-923295, a CENP-E inhibitor, is being developed under the strategic alliance by GSK. GSK is expected to begin clinical trials with GSK-923295 in 2007. All of these drug candidates have arisen from Cytokinetics research activities and are directed towards the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. Cytokinetics focus on the cytoskeleton enables it to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, and cardiovascular disease. Additional information about Cytokinetics can be obtained at www.cytokinetics.com.

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the ?Act?). Cytokinetics disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, statements relating to the expected initiation, timing, conduct, scope and results of Cytokinetics and its partners research and development programs, including initiation of clinical trials; anticipated dates of release of data from clinical trials; the potential benefits of Cytokinetics drug candidates and potential drug candidates, including the benefits of mitotic kinesin i
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:9/4/2015)... Sept. 4, 2015  Allergan plc (NYSE: AGN ) ... Saunders , CEO and President of Allergan, will provide an ... Stanley Global Healthcare Conference 2015 in New York, ... The presentation will take place on Thursday, ... Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Veterinary Pharmaceutical Submissions ... 2015)" conference to their offering. ... all of the constituent parts of the application ... for which a marketing authorisation is sought in ...
(Date:9/4/2015)... MENLO PARK, Calif. , Sept. 4, 2015 /PRNewswire/ ... the "Company"), a biopharmaceutical company focused on the development ... financial results for the fiscal year ending June 30, ... and expected near-term milestones. DelMar,s management ... live webcast for investors, analysts and other interested parties ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8
... HOUSTON , May 5 eCardio announced today the appointment of ... the company as Vice President of Business Development. , ... (Photo:   http://www.newscom.com/cgi-bin/prnh/20100505/DA98655 ) , , , ... for mobile health technology and the tremendous growth of eCardio," noted Robert Jordan ...
... SHENZHEN, China , May ... WWIN ; "Winner Medical" or the "Company"), a leading ... the medical and consumer products industries, today announced that ... fiscal year 2010 on, Tuesday, May 11 , before ...
Cached Medicine Technology:eCardio Appoints Key Member to Corporate Executive Team 2Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 2Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 3Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 4
(Date:9/4/2015)... ... ... and Overseer at The House of Yahweh, has written an open letter to Pope Francis ... United States. , Yisrayl lays out what he says is the true meaning of the ... provides the meaning of his own name and describes what bible prophecy says about his ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce ... the norm not the exception. , St. Jude was recently named one of the ... Association, making it one of only 10 hospitals in the state to earn the ...
(Date:9/3/2015)... ... September 03, 2015 , ... William Mattar Law Offices is known for ... does not stop at any certain demographic or segment of the population. Because ... fifteen- and ten-second TV commercials. , The closed captioning will allow people with hearing ...
(Date:9/3/2015)... ... 2015 , ... The Beryl Institute announces 52 breakout sessions ... April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience Conference is the ... healthcare leaders, staff, physicians, patients and families across the globe to convene, engage ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3
... dengue fever in the state has been brought out ... aegypti, mosquito is the common carrier of both chikungunya ... has taken up an integrated mosquito control programme involving ... areas in every house will be examined. ...
... proteins in the eye is the main trigger for ... researchers at Case Western Reserve University and the Cleveland ... one of the main reasons for the development of ... among people over 65 in the United States. ...
... depression and falls all increase risk of developing a ... a particularly effective way to reduce the nation’s disability ... efforts that combine education about risks with exercise, home ... least in the short run, found researchers led by ...
... an insight into how effective the lead petrol ban has ... of the otters killed by cars //since 1992 has found ... a valuable pointer for human health as well since lead ... well as affect the kidney. ,Researcher Dr. Liz ...
... Inc., confirms their plans to go into a partnership ... journal.// ,International publisher John Wiley & Sons, ... plans of a new agreement with the North American ... the American Association for the Study of Liver Diseases ...
... and uncertainty as a part of it. However, the ... of nuclear power stations and flu pandemic// has generated ... do something to re-build trust in politicians and scientists. ... risk originates from emotions and not logic, particularly, when ...
Cached Medicine News:Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Preventing Falls May Be Key to Avoiding Disability in Elderly 2Health News:Danger and insecurity in contemporary life 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: